| Persistence of Ebola virus in ocular fluid during convalescence JB Varkey, JG Shantha, I Crozier, CS Kraft, GM Lyon, AK Mehta, G Kumar, ... New England Journal of Medicine 372 (25), 2423-2427, 2015 | 527 | 2015 |
| Ebola virus persistence in semen of male survivors TM Uyeki, BR Erickson, S Brown, AK McElroy, D Cannon, A Gibbons, ... Clinical Infectious Diseases 62 (12), 1552-1555, 2016 | 131 | 2016 |
| Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH M Kainulainen, M Habjan, P Hubel, L Busch, S Lau, J Colinge, ... Journal of virology 88 (6), 3464-3473, 2014 | 97 | 2014 |
| Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication A Baer, D Austin, A Narayanan, T Popova, M Kainulainen, C Bailey, ... Journal of Biological Chemistry 287 (10), 7399-7410, 2012 | 97 | 2012 |
| NSs virulence factor of rift valley fever virus engages the F-box proteins FBXW11 and β-TRCP1 to degrade the antiviral protein kinase PKR M Kainulainen, S Lau, CE Samuel, V Hornung, F Weber Journal of virology 90 (13), 6140-6147, 2016 | 75 | 2016 |
| Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice FEM Scholte, JR Spengler, SR Welch, JR Harmon, JAD Coleman-McCray, ... Emerging Microbes & Infections 8 (1), 575-578, 2019 | 51 | 2019 |
| Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines L Wang, MH Kainulainen, N Jiang, H Di, G Bonenfant, L Mills, M Currier, ... Nature communications 13 (1), 4350, 2022 | 45 | 2022 |
| Antibody-mediated virus neutralization is not a universal mechanism of Marburg, Ebola, or Sosuga virus clearance in Egyptian rousette bats AJ Schuh, BR Amman, TK Sealy, MH Kainulainen, AK Chakrabarti, ... The Journal of infectious diseases 219 (11), 1716-1721, 2019 | 43 | 2019 |
| Use of a scalable replicon-particle vaccine to protect against lethal Lassa virus infection in the guinea pig model MH Kainulainen, JR Spengler, SR Welch, JAD Coleman-McCray, ... The Journal of infectious diseases 217 (12), 1957-1966, 2018 | 35 | 2018 |
| Ebola virus disease diagnostics, Sierra Leone: Analysis of real-time reverse transcription–polymerase chain reaction values for clinical blood and oral swab specimens BR Erickson, TK Sealy, T Flietstra, L Morgan, B Kargbo, VE Matt-Lebby, ... The Journal of Infectious Diseases 214 (suppl_3), S258-S262, 2016 | 32 | 2016 |
| eIF2B as a target for viral evasion of PKR-mediated translation inhibition JD Wuerth, M Habjan, M Kainulainen, B Berisha, D Bertheloot, ... MBio 11 (4), 10.1128/mbio. 00976-20, 2020 | 22 | 2020 |
| Protection from lethal Lassa disease can be achieved both before and after virus exposure by administration of single-cycle replicating Lassa virus replicon particles MH Kainulainen, JR Spengler, SR Welch, JAD Coleman-McCray, ... The Journal of infectious diseases 220 (8), 1281-1289, 2019 | 21 | 2019 |
| Lassa virus targeting of anterior uvea and endothelium of cornea and conjunctiva in eye of guinea pig model JM Gary, SR Welch, JM Ritter, JA Coleman-McCray, T Huynh, ... Emerging Infectious Diseases 25 (5), 865, 2019 | 19 | 2019 |
| The S genome segment is sufficient to maintain pathogenicity in intra-clade Lassa virus reassortants in a guinea pig model SR Welch, FEM Scholte, CG Albariño, MH Kainulainen, ... Frontiers in Cellular and Infection Microbiology 8, 240, 2018 | 19 | 2018 |
| Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus IA Durie, ZR Tehrani, E Karaaslan, TE Sorvillo, J McGuire, JW Golden, ... Nature communications 13 (1), 7298, 2022 | 18 | 2022 |
| High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay MH Kainulainen, E Bergeron, P Chatterjee, AP Chapman, J Lee, A Chida, ... Scientific Reports 11 (1), 12330, 2021 | 17 | 2021 |
| Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies AP Chapman, X Tang, JR Lee, A Chida, K Mercer, RE Wharton, ... Scientific reports 11 (1), 9682, 2021 | 17 | 2021 |
| Transmission of SARS‐CoV‐2 Delta variant (B. 1.617. 2) from a fully vaccinated human to a canine in Georgia, July 2021 NM Wendling, A Carpenter, A Liew, RR Ghai, N Gallardo‐Romero, ... Zoonoses and Public Health 69 (5), 587-592, 2022 | 16 | 2022 |
| Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions FEM Scholte, E Karaaslan, TJ O’Neal, TE Sorvillo, SC Genzer, SR Welch, ... Frontiers in Cellular and Infection Microbiology 13, 1233148, 2023 | 15 | 2023 |
| Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination SR Welch, JR Spengler, SC Genzer, JAD Coleman-McCray, JR Harmon, ... Science Advances 9 (31), eadh4057, 2023 | 13 | 2023 |
